Chemoreactome analysis of the antithrombotic effects of glucosamine sulfate and nonsteroidal anti-inflammatory drugs

Chemoreactome analysis of the antithrombotic effects of glucosamine sulfate and nonsteroidal anti-inflammatory drugs

Nonsteroidal anti-inflammatory drugs (NSAIDs) are among the most effective medications in modern pharmacotherapy. At the same time, it has been established that NSAIDs can cause cardiovascular diseases. Glucosamine sulfate (GS) is used in the therapy of osteoarthritis and, according to experimental...

Full description

Saved in:

Bibliographic Details
Main Authors:	O. A. Gromova, I. Yu. Torshin, A. M. Lila, A. V. Naumov, K. V. Rudakov
Format:	Article
Language:	Russian
Published:	IMA-PRESS LLC 2019-03-01
Series:	Современная ревматология
Subjects:	glucosamine sulfate (sustaguard artro) acetylsalicylic acid dexketoprofen diclofenac meloxicam chemoreactome analysis
Online Access:	https://mrj.ima-press.net/mrj/article/view/898
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Differential chemoreactome analysis of glucosamine sulfate and non-steroidal anti-inflammatory drugs: promising synergistic drug combinations
by: O. A. Gromova, et al.
Published: (2018-06-01)

Is it worthwhile rethinking the positive experience of the last 50 years of using chondroitin sulfates against atherosclerosis?
by: A. M. Lila, et al.
Published: (2020-08-01)

Comparative clinical and economic analysis of the use of symptomatic slow-acting drugs containing glucosamine sulfate in patients with Stage II gonarthrosis during outpatient care
by: I. V. Sarvilina, et al.
Published: (2019-12-01)

On the anticoagulant and antiaggregatory properties of a glucosamine sulfate molecule
by: I. Yu. Torshin, et al.
Published: (2019-09-01)

Hepatoprotective effects of chondroitin sulfate and glucosamine sulfate
by: I. Yu. Torshin, et al.
Published: (2022-01-01)

Prospects for the use of chondroitin sulfate and glucosamine sulfate with osteoarthritis associated with pathology of the kidneys and urinary system
by: I. Yu. Torshin, et al.
Published: (2020-04-01)

Russian experience with injectable chondroitin sulfate and glucosamine sulfate: a review of clinical trials
by: A. E. Karateev, et al.
Published: (2018-04-01)

Acute issues in the pharmacotherapy of hand osteoarthritis
by: O. A. Gromova, et al.
Published: (2021-02-01)

The efficacy and tolerability of the slow-acting combined agent glucosamine and chondroitin sulfate in gonarthrosis patients tacking no nonsteroidal anti-inflammatory drugs
by: A. P. Rebrov, et al.
Published: (2016-01-01)

Effect glucosamine sulfate drug on liver tissue of male Albino mice
by: Baghdad Science Journal
Published: (2015-06-01)

Chemomicrobiomic analysis of glucosamine sulfate, prebiotics and non-steroidal anti-inflammatory drugs
by: O. A. Gromova, et al.
Published: (2020-11-01)

Comparison of Glucosamine-Chondroitin Sulfate with and without Methylsulfonylmethane in Grade I-II Knee Osteoarthritis: A Double Blind Randomized Controlled Trial
by: Andri M.T. Lubis, et al.
Published: (2017-08-01)

Hand osteoarthritis: pathogenesis, diagnosis, and approaches to therapy
by: N. A. Shostak, et al.
Published: (2019-10-01)

Evaluation of the efficacy and safety of a combination of chondroitin sulfate and glucosamine sulfate for knee and hip osteoarthritis in real clinical practice
by: A. E. Karateev, et al.
Published: (2020-11-01)

CURRENT PHARMACOTHERAPY FOR KNEE OSTEOARTHRITIS: SPECIFIC FEATURES OF SYMPTOMATIC AND DISEASE MODIFYING EFFECTS. COMMUNICATION 1. SPECIFIC FEATURES OF THE SYMPTOMATIC EFFECTS OF CURRENT DRUGS TO TREAT KNEE OSTHEOARTHRITIS
by: E. S. Tsvetkova, et al.
Published: (2015-03-01)

Chemoreactomic analysis of the antioxidant properties of vitamin B12 derivatives
by: I. Yu. Torshin, et al.
Published: (2024-11-01)

Chemoreactome analysis of 7-hydroxymatairesinol, 17-estradiol, phytoestrogen β-sitosterol and epigallocatechin-3-gallate
by: I. Yu. Torshin, et al.
Published: (2020-09-01)

Evidence-based therapy for knee osteoarthritis: expected short-, medium-, and long-term outcomes of prescription crystalline glucosamine sulfate administration
by: L. N. Denisov, et al.
Published: (2022-08-01)

Chemoreactome screening of pharmaceutical effects on SARS-CoV-2 and human virome to help decide on drug-based COVID-19 therapy
by: I. Yu. Torshin, et al.
Published: (2021-07-01)

Diclofenac sodium vs. dexketoprofen trometamol: selecting NSAIDs for managing postoperative inflammatory complications after third molar surgery—a randomized clinical trial
by: Mahmut Erkal, et al.
Published: (2025-05-01)

Prospects of using chondroprotectors for the treatment of pulmonary pathology
by: I. Yu. Torshin, et al.
Published: (2022-01-01)

On the immunotropic effects of a new combined pharmaconutraceutical preparation in osteoarthritis
by: I. V. Sarvilina, et al.
Published: (2024-08-01)

Knee osteoarthrosis: Clinical presentation, diagnosis, treatment
by: Vladimir Vasilyevich Badokin
Published: (2013-10-01)

Basic symptom-modifying delayed-action drugs in therapy of osteoporosis
by: Vladimir Vasil'evich Badokin, et al.
Published: (2011-09-01)

Showiness or efficiency: what to choose?
by: D.G. Rekalov, et al.
Published: (2013-08-01)

Osteoarthritis background therapy: current view on the glucosamine and chondroitin therapy
by: L. I. Alekseeva, et al.
Published: (2021-04-01)

Preparation of 123-iodine labeled glucosamine derivative and investigation of its biological properties
by: M. S. Larkina, et al.
Published: (2018-03-01)

From misconceptions to reasonable osteoarthritis patients therapy
by: O. A. Shavlovskaya, et al.
Published: (2023-07-01)

Multimorbidity in osteoarthritis and pleiotropic effects of slow-acting symptomatic drugs. Resolution of the multidisciplinary International Expert Council
by: V. I. Mazurov, et al.
Published: (2023-10-01)

Study of Glucosamine Production from Shrimp Shells by Fermentation Using Trichoderma harzianum
by: Hardoko Hardoko, et al.
Published: (2017-12-01)

NONSTEROIDAL ANTI-INFLAMMATORY DRUGS: CURRENT ASPECTS OF THEIR USE
by: N. A. Shostak, et al.
Published: (2014-07-01)

Combination therapy for exacerbations of pain in osteoarthritis with non-fixed combinations
by: Anton V. Naumov, et al.
Published: (2025-01-01)

A Novel Glucosamine-Based Cannabidiol Complex Based on Intermolecular Bonding with Improved Water Solubility
by: Mitja Križman, et al.
Published: (2025-07-01)

Experimental and Acomparative Study for the effect of GlucosAmine hydrochloride as Antioxidant in Sera of Adult Male Rabbits
by: Rafah Razooq Hameed Al- Samarrai, et al.
Published: (2023-02-01)

Disease-modifying osteoarthritis drugs (DMOADs): new trends in osteoarthritis therapy
by: O. A. Shavlovskaya, et al.
Published: (2023-11-01)

The side effect profile of nonsteroidal anti-inflammatory drugs for rheumatic
by: T A Raskina, et al.
Published: (2011-12-01)

THE SELECTION PROBLEMS OF ANTITHROMBOTIC THERAPY IN NONVALVULAR ATRIAL FIBRILLATION WITH COMORBIDITIES
by: N. A. Koziolova, et al.
Published: (2015-08-01)

Osteoarthritis: management strategies depending on the location of lesions
by: N. A. Shostak, et al.
Published: (2022-07-01)

A sound approach to choosing nonsteroidal anti-inflammatory drugs for osteoarthritis
by: E. V. Zonova, et al.
Published: (2018-12-01)

Treatment in patients with osteoarthritis at different sites: Place of slow-acting drugs
by: N. V. Chichasova, et al.
Published: (2015-06-01)